CIK 0001655923 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Alpha Cognition Inc.
Sign in to watch- Ticker
- ACOG
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (858) 344-4375
- Business address
- 1452 HUGHES RD., STE. 200, GRAPEVINE, TX, 76051
- Former names
- Neurodyn Cognition Inc.
- 4 Open-market buy 10% owner bought 24,376 shares at an average $5.77 ($140,545)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market buy Chief Operating Officer bought 3,500 shares at $5.76 ($20,160)
- 4 Open-market buy 10% owner bought 34,043 shares at an average $5.76 ($196,009)
- 10-Q Report Quarterly Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K/A Event Executive or director change
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
- 4 Grant or award Director acquired 5,489 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement
- 10-K Report Annual Report
- 4 Open-market buy 10% owner bought 11,850 shares at an average $5.06 ($60,019)
- 8-K Event Regulation FD disclosure
- 4 Open-market buy 10% owner bought 20,082 shares at an average $5.41 ($108,631)
- 8-K Event Results of operations
- 4 Open-market buy 10% owner bought 4,575 shares at an average $5.73 ($26,214)
Page 2 of 11 · 217 filings